Title: | Development of Chiral Auxiliaries from (-)-Levoglucosenone and Biomimetic Synthesis of Mitchellenes B–H |
Contributor(s): | Klepp, Julian (author); Greatrex, Ben (supervisor) ; Fellows, Christopher (supervisor) |
Conferred Date: | 2019-12-20 |
Copyright Date: | 2019-10 |
Handle Link: | https://hdl.handle.net/1959.11/57139 |
Related DOI: | 10.1055/s-0037-1610148 10.1021/acs.joc.9b00961 10.1021/acs.jnatprod.7b00616 10.1016/j.tet.2019.05.051 |
Abstract: | | There is an increasing urgency to transition from a petroleum-based economy using
environmentally damaging extraction to a sustainable and environmentally friendly
alternative. This change will require chemists to face the task of finding green platform
chemicals to replace those produced from fossil commodities, a challenge which requires the
development of chemistries that utilise materials abundant in nature. The aim of this thesis
was to chemically modify molecules that derive from plants and convert them into
biorenewable chemicals such as chiral auxiliaries (Part I) and scaffolds for drug discovery
(Part II).
Part I. Development of Chiral Auxiliaries from (-)-Levoglucosenone
The first part of this work was focused on transforming the chiral cellulose pyrolysis
product (-)-levoglucosenone (LGO, II) into chiral auxiliaries that could be prepared in bulk,
enabling resource savings and waste reduction.
After having developed a reliable and scalable preparation protocol of LGO (II) from
cellulose (I) using sulfuric acid in polyethylene glycol (Chapter 2), II was converted into
several auxiliaries (Chapter 3) that were compared in terms of simplicity and efficiency of
synthesis, as well as diastereoselective induction in chemical transformations. Among those
chiral auxiliaries prepared, was compound III that could be obtained in three steps with an
overall yield of 86%. This work is of significance as III could be produced on scale (>200 g)
from inexpensive chemicals without the need for chromatography. Auxiliary III was
successfully employed in the Lewis acid catalysed Diels-Alder (V, Chapter 4) and sulfaMichael reactions (X, Chapter 5) allowing access to important chiral building blocks and
targets (VI–VIII). The selectivity of the asymmetric transformations could be explained by
p-stacking interactions of the diaryl system with the reacting double bond. The mechanism
by which Lewis acids promoted selectivity was determined through low temperature NMR
experiments (XI, Chapter 4).
Part II. Biomimetic Synthesis of Mitchellenes B–H
The second part of this work focused on examining the secondary metabolites of the
Australian bush plant E. Sturtii as a source of both new chemistry and potential scaffolds with
drug-like properties.
The phytochemical investigation (Chapter 7) led to the discovery of four new natural
products (XVII–XX) as well as large quantities (>20 g) of muurolane XII that could be
isolated without the need for chromatography. During the investigations of the biosynthetic
origins of the mitchellene family, XII was successfully converted into mitchellene B (XVI,
Chapter 8) via a short and efficient series of domino processes. The key steps were redox
isomerisation-esterification, dynamic kinetic resolution/Stetter reaction and reductionepimerisation. The synthesis was completed by an α-selenation with LDA/PhSeCl followed
by an oxidative elimination using hydrogen peroxide affording XVI with an overall yield of
22%. Thus, the three additional stereocentres were selectively installed in only four steps.
Starting from XII, the mitchellenes XVII–XX could also be obtained. XVI proved to be a
particularly interesting scaffold for drug discovery, not just because it was abundant, but also
for its substrate controlled stereoselective reactions on its double bond, without the need for
ligands or catalysts for control. This led to the development of a screening library (Chapter 9)
from which was identified two non-toxic, antifungal compounds (XVII and XXIII). During
this work, an unusual syn-b,d-diarylation of XVI under Pd-mediated reductive Heck
conditions (XXVI) was also discovered.
Publication Type: | Thesis Doctoral |
Fields of Research (FoR) 2020: | 340401 Biologically active molecules 340503 Organic chemical synthesis |
Socio-Economic Objective (SEO) 2020: | 240908 Organic industrial chemicals (excl. resins, rubber and plastics) 280105 Expanding knowledge in the chemical sciences |
HERDC Category Description: | T2 Thesis - Doctorate by Research |
Description: | | Please contact rune@une.edu.au if you require access to this thesis for the purpose of research or study.
Chancellor's Doctoral Research Medal awarded on 20th December, 2019
Appears in Collections: | School of Rural Medicine School of Science and Technology Thesis Doctoral
|